Quantitative Real-time Polymerase Chain Reaction (qRT-PCR) and Western blot further confirmed the upregulation of IGF2BP3 in CRC (Fig. 1c, d and S1d). This evidence concerns the gene IGF2BP3 and colorectal carcinoma.